相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study
Oscar Arrieta et al.
BMC CANCER (2010)
The immunologic aspects in advanced ovarian cancer patients treated with paclitaxel and carboplatin chemotherapy
Xia Wu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Multiple molecular mechanisms underlying trastuzumab and lapatinib resistance in JIMT-1 breast cancer cells
Katri Koninki et al.
CANCER LETTERS (2010)
Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3) as a targeted cancer immunotherapy
Diane Seimetz et al.
CANCER TREATMENT REVIEWS (2010)
The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: results of a prospective randomized phase II/III trial
Markus M. Heiss et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Mechanisms of resistance to anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer
Zacharenia Saridaki et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Weekly Paclitaxel and Trastuzumab as a First-Line Therapy in Patients with HER2-Overexpressing Metastatic Breast Cancer: Magnitude of HER2/neu Amplification as a Predictive Factor for Efficacy
Hye-Suk Han et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2009)
Test System for Trifunctional Antibodies in 3D MCTS Culture
Franziska Hirschhaeuser et al.
JOURNAL OF BIOMOLECULAR SCREENING (2009)
The anticancer immune response: indispensable for therapeutic success?
Laurence Zitvogel et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Effect of frequently used chemotherapeutic drugs on cytotoxic activity of human cytotoxic T-lymphocytes
Laszlo Markasz et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Immunological aspects of cancer chemotherapy
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Characterisation of the new EpCAM-specific antibody HO-3:: implications for trifunctional antibody immunotherapy of cancer
P. Ruf et al.
BRITISH JOURNAL OF CANCER (2007)
Phase I trial of the trifunctional anti-HER2 x anti-CD3 antibody ertumaxomab in metastatic breast cancer
Philipp Kiewe et al.
CLINICAL CANCER RESEARCH (2006)
Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: A preclinical study
JK Chan et al.
CLINICAL CANCER RESEARCH (2006)
Anti-CD3 x anti-epidermal growth factor receptor (EGFR) bispecific antibody redirects T-cell cytolytic activity to EGFR-positive cancers in vitro and in an animal model
U Reusch et al.
CLINICAL CANCER RESEARCH (2006)
Trifunctional bispecific antibody-induced tumor cell lysis of squamous cell carcinomas of the upper aerodigestive tract
SS Gronau et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2005)
Immune dysfunction and micrometastases in women with breast cancer
MJ Campbell et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
T cells armed with anti-CD3 x anti-CD20 bispecific antibody enhance killing of CD20+ malignant B cells and bypass complement-mediated rituximab resistance in vitro
JM Gall et al.
EXPERIMENTAL HEMATOLOGY (2005)
Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy
M Zignol et al.
CANCER (2004)
Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes
CT Garnett et al.
CANCER RESEARCH (2004)
Efficient tumor cell lysis by autologous, tumor-resident T lymphocytes in primary ovarian cancer samples by an Ep-CAM-/CD3-bispecific antibody
P Wimberger et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Immune modulation by ionizing radiation and its implications for cancer immunotherapy
EJ Friedman
CURRENT PHARMACEUTICAL DESIGN (2002)
Molecular downstream events and induction of thymidylate synthase in mutant and wild-type p53 colon cancer cell lines after treatment with 5-fluorouracil and the thymidylate synthase inhibitor raltitrexed
GJ Peters et al.
EUROPEAN JOURNAL OF CANCER (2000)
分享论文
